ABOUT US

We are a forward-thinking, mid-size early phase contract research organization, in Canada and the U.S., offering biopharmaceutical companies of all sizes a proven, flexible approach to early drug development, including preclinical safety testing, clinical pharmacology (Phase I to Phase II), bioanalysis (preclinical to Phase IV), research services, and manufacturing and analytical services. Focused on your success … always available and always looking ahead. Moving in unison to deliver big impact with a personal touch.

More About Us

...working with Altasciences has been excellent, from both a bioanalytical, and a bioavailability study perspective. We are really impressed with their planning and execution abilities – I would not consider another provider for future work.

James M Mackay, President and Chief Executive Officer, Aristea Therapeutics

RESOURCE CENTER

Blog - Protocol Design Concepts in Phase I Ethnobridging Clinical Trials

Read the blog

Protocol Design Concepts in Phase I Ethnobridging Clinical Trials

In Phase I ethnobridging clinical trials, there are three primary protocol design concepts utilized. These concepts align the strategy with global clinical development and measure key factors necessary for meeting the unique needs of the Sponsor.

View All News & Events Go to Resource Center

SELECT A CATEGORY BELOW:

The Altascientist Scientific journal
eBulletins Highlights on key topics
Newsletters Latest industry and corporate news
Scientific Publications Posters, case studies and abstracts
Blog
Videos

Careers

Join our team! Work at Altasciences - View all clinical job postings

Bring your talents and forward-thinking approach to Altasciences and help us develop medicines for those who need them, faster. We have a number of opportunities for you to explore.

Learn More

NEWS & EVENTS

A starry night with chemical-like webbing and the words "Altasciences Acquires WCCT Global" written over top.

Press Release

Altasciences Acquires WCCT Global

Altasciences is expanding its current clinical operations in Montreal and Kansas City with the addition of a clinical CRO on the U.S.A.'s West Coast. Click below to read more about the acquisition of WCCT Global.

View All News & Events Go to Resource Center

SELECT A CATEGORY BELOW:

Altasciences Events
Press Releases
Altasciences in the News
Press Kit
Webinars / Podcasts

Our Solutions

December 2020

In this issue
Examine our bioanalytical assay list, new scientific publications, webinars, podcasts, and more, covering our full-service preclinical, clinical and manufacturing solutions…

QUICK LINKS

Message from Our CEO — Year-End Message

Updated assay list

Industry news

The Altascientist

Early phase research continuity in the era of COVID-19

READ MORE

Species Selection for your Preclinical Program
Ensuring supply

READ THE ARTICLE

Considerations for Optimal Study Design for Clinical Trials
Obtaining the comprehensive, quality data you need

READ THE ARTICLE

Scientific Publications
The latest developments from our scientists.

VIEW ALL

CONTINUE READING

  • Webinars
    View the latest on-demand webinars and catch up on some of our favorites from 2020.
  • Podcasts
    Hot topics and insight into the industry — listen to Altasciences’ podcasts wherever you go.
  • Up Close and Personal with…
    Meet Lynne Le Sauteur, PhD, Vice President, Laboratory Sciences at Altasciences.
  • Blog
    Learn how to improve solubility of molecules via nanomilling… and more from other insightful posts.

LET'S STAY CONNECTED!

2021 © Altasciences. All Rights Reserved.

Cookie Policy | Privacy Policy